AAAAAA
Results:
1-25
|
Results: 25
Authors:
MARTIN WL
DURRANT LG
LIU DTY
Citation: Wl. Martin et al., NONINVASIVE FETAL CELL ISOLATION FROM MATERNAL BLOOD, British journal of obstetrics and gynaecology, 105(6), 1998, pp. 576-583
Authors:
ARMSTRONG CAM
DURRANT LG
ROBINS RA
GALVIN AM
SCHOLEFIELD JH
HARDCASTLE JD
Citation: Cam. Armstrong et al., COLORECTAL-CANCER VACCINE 105AD7 INCREASES TUMOR INFILTRATION OF CD25-POSITIVE LYMPHOCYTES, British Journal of Surgery, 85(5), 1998, pp. 699-699
Authors:
MAXWELLARMSTRONG CA
DURRANT LG
SCHOLEFIELD JH
Citation: Ca. Maxwellarmstrong et al., COLORECTAL-CANCER VACCINES, British Journal of Surgery, 85(2), 1998, pp. 149-154
Authors:
POTTER V
SPENDLOVE I
DURRANT LG
Citation: V. Potter et al., DNA VACCINATION WITH A SCFV OF THE ANTIIDIOTYPE ANTIBODY 105AD7 INDUCES A TH1 IMMUNE-RESPONSE, British Journal of Cancer, 78, 1998, pp. 55-55
Authors:
DURRANT LG
SPENDLOVE I
MAXWELLARMSTRONG C
BUCKLEY D
ROBINS RA
CARMICHAEL J
HARDCASTLE JD
Citation: Lg. Durrant et al., DOUBLE-BLIND RANDOMIZED TRIAL OF 105AD7 VACCINE, European journal of cancer, 33, 1997, pp. 369-369
Authors:
DURRANT LG
Citation: Lg. Durrant, CANCER VACCINES, Anti-cancer drugs, 8(8), 1997, pp. 727-733
Authors:
DURRANT LG
BUCKLEY DJ
SPENDLOVE I
ROBINS RA
Citation: Lg. Durrant et al., LOW-DOSES OF 105AD7 CANCER VACCINE PREFERENTIALLY STIMULATE ANTITUMORT-CELL IMMUNITY, Hybridoma, 16(1), 1997, pp. 23-26
Authors:
ARMSTRONG CAM
DURRANT LG
GALVIN AM
ROBINS RA
SCHOLEFIELD JH
HARDCASTLE JD
Citation: Cam. Armstrong et al., 105AD7 IS AN ANTIIDIOTYPIC ANTIBODY THAT ENHANCES LYMPHOCYTIC INFILTRATION OF PRIMARY COLORECTAL TUMORS WITHOUT CHANGES IN PERIPHERAL-BLOODLYMPHOCYTE SUB-SET LEVELS, Gastroenterology, 112(4), 1997, pp. 611-611
Authors:
MAXWELLARMSTRONG CA
DURRANT LG
GALVIN AM
ROBINS RA
SCHOLEFIELD JH
HARDCASTLE JD
Citation: Ca. Maxwellarmstrong et al., TUMOR INFILTRATION OF CD4-CANCER VACCINE 105AD7( LYMPHOCYTES EXPRESSING THE ACTIVATION MARKER CD25, IS INCREASED FOLLOWING IMMUNIZATION WITH THE COLORECTAL), Gastroenterology, 112(4), 1997, pp. 612-612
Authors:
MAXWELLARMSTRONG CA
DURRANT LG
GALVIN AM
ROBINS RA
SCHOLEFIELD JH
HARDCASTLE JD
Citation: Ca. Maxwellarmstrong et al., INTERLEUKIN-2 EXPRESSION BY LYMPHOCYTES INFILTRATING PRIMARY COLORECTAL CANCERS IS ENHANCED FOLLOWING IMMUNIZATION WITH THE ANTIIDIOTYPIC ANTIBODY 105AD7, Gastroenterology, 112(4), 1997, pp. 612-612
Authors:
DURRANT LG
SPENDLOVE I
Citation: Lg. Durrant et I. Spendlove, CANCER VACCINES, Quarterly Journal of Medicine, 89(9), 1996, pp. 645-651
Authors:
FILIPE MI
LINEHAN JM
DURRANT LG
PRICE MR
SMEETON NC
PATHAK S
SWALLOW DM
Citation: Mi. Filipe et al., EXPRESSION OF A PEPTIDE EPITOPE OF THE COLONIC MUCIN MUC2 IN PRECURSOR LESIONS TO GASTRIC-CARCINOMA, European journal of cancer prevention, 5(4), 1996, pp. 287-295
Authors:
DURRANT LG
MARTIN WL
MCDOWALL KM
LIU DTY
Citation: Lg. Durrant et al., ISOLATION OF FETAL TROPHOBLASTS AND NUCLEATED ERYTHROCYTES FROM THE PERIPHERAL-BLOOD OF PREGNANT-WOMEN FOR PRENATAL-DIAGNOSIS OF FETAL ANEUPLOIDES, Early human development, 47, 1996, pp. 79-83
Authors:
WRITER MJ
NIRULA R
SPENDLOVE IS
DURRANT LG
Citation: Mj. Writer et al., MOLECULAR MIMICRY OF CEA BY AN ANTIIDIOTYPIC ANTIBODY, Immunology, 89, 1996, pp. 8-8
Authors:
ARMSTRONG CAM
DURRANT LG
ROBINS RA
SCHOLEFIELD JH
HARDCASTLE JD
Citation: Cam. Armstrong et al., THE ANTIIDIOTYPIC MONOCLONAL-ANTIBODY 105AD7 INCREASES EXPRESSION OF THE INTERLEUKIN-2 RECEPTOR BY LYMPHOCYTES WITHIN COLORECTAL CANCERS, Immunology, 89, 1996, pp. 26-26
Authors:
BUCKLEY DJ
CHAPMAN MA
DURRANT LG
ROBINS RA
ARMITAGE NC
Citation: Dj. Buckley et al., INCREASED EXPRESSION OF 791T-GP72 PREDICTS A POOR-PROGNOSIS IN COLORECTAL-CANCER, Gastroenterology, 110(4), 1996, pp. 497-497
Authors:
CARPENTER KM
DURRANT LG
MORGAN K
BENNETT D
HARDCASTLE JD
KALSHEKER NA
Citation: Km. Carpenter et al., GREATER FREQUENCY OF K-RAS VAL-12 MUTATION IN COLORECTAL-CANCER AS DETECTED WITH SENSITIVE METHODS, Clinical chemistry, 42(6), 1996, pp. 904-909
Authors:
CARPENTER K
MORGAN K
DURRANT LG
HARDCASTLE JD
KALSHEKER N
Citation: K. Carpenter et al., SENSITIVITY OF COMPETITIVE HYBRIDIZATION FOR THE DETECTION OF MUTANT P53 ALLELES IN A BACKGROUND OF WILD-TYPE, Biochemical Society transactions, 23(1), 1995, pp. 129-129
Authors:
DURRANT LG
DORAN M
AUSTIN EB
ROBINS RA
Citation: Lg. Durrant et al., INDUCTION OF CELLULAR IMMUNE-RESPONSES BY A MURINE MONOCLONAL ANTIIDIOTYPIC ANTIBODY RECOGNIZING THE 791TGP72 ANTIGEN EXPRESSED ON COLORECTAL, GASTRIC AND OVARIAN HUMAN TUMORS, International journal of cancer, 61(1), 1995, pp. 62-66
Authors:
BUCKLEY DJ
DENTON GW
ROBINS RA
SEWELL HF
HARDCASTLE JD
DURRANT LG
Citation: Dj. Buckley et al., ACCUMULATION OF CYTOLYTIC T-CELLS DURING 105AD7 ANTIIDIOTYPIC THERAPYIN ADVANCED COLORECTAL-CANCER PATIENTS, Gastroenterology, 108(4), 1995, pp. 452-452
Authors:
DURRANT LG
JACOBS E
PRICE MR
Citation: Lg. Durrant et al., PRODUCTION OF MONOCLONAL-ANTIBODIES RECOGNIZING THE PEPTIDE CORE OF MUC2 INTESTINAL MUCIN, European journal of cancer, 30A(3), 1994, pp. 355-363
Authors:
DURRANT LG
MCDOWELL KM
HOLMES RA
LIU DTY
Citation: Lg. Durrant et al., SCREENING OF MONOCLONAL-ANTIBODIES RECOGNIZING ONCOFETAL ANTIGENS FORISOLATION OF TROPHOBLASTS FROM MATERNAL BLOOD FOR PRENATAL-DIAGNOSIS, Prenatal diagnosis, 14(2), 1994, pp. 131-140
Authors:
DENTON GWL
DURRANT LG
HARDCASTLE JD
AUSTIN EB
SEWELL HF
ROBINS RA
Citation: Gwl. Denton et al., CLINICAL OUTCOME OF COLORECTAL-CANCER PATIENTS TREATED WITH HUMAN MONOCLONAL ANTIIDIOTYPIC ANTIBODY, International journal of cancer, 57(1), 1994, pp. 10-14
Authors:
DURRANT LG
BUCKLEY TJD
DENTON GWL
HARDCASTLE JD
SEWELL HF
ROBINS RA
Citation: Lg. Durrant et al., ENHANCED CELL-MEDIATED TUMOR KILLING IN PATIENTS IMMUNIZED WITH HUMANMONOCLONAL ANTIIDIOTYPIC ANTIBODY 105AD7, Cancer research, 54(18), 1994, pp. 4837-4840
Authors:
DURRANT LG
SINGHAL A
JACOBS E
PRICE MR
Citation: Lg. Durrant et al., DEVELOPMENT OF 2ND-GENERATION MONOCLONAL-ANTIBODIES RECOGNIZING LEWIS(Y B) ANTIGEN BY ANTIIDIOTYPIC IMMUNIZATION/, Hybridoma, 12(6), 1993, pp. 647-660
Risultati:
1-25
|